Pfizer Inc. is set to unveil plans to lower prescription drug prices at an event on Tuesday alongside President Donald Trump, according to multiple White House officials. The announcement will include measures aimed at making medicines more affordable for Americans, particularly those enrolled in the Medicaid program.

Pfizer is expected to implement broad reductions in US drug prices, with Medicaid patients receiving “most favored nation” pricing on select medicines. This approach aligns with Trump’s ongoing push to bring US drug costs in line with what foreign purchasers pay.

Investment in R&D and domestic manufacturing

Pfizer will announce a $70 billion investment in research, development, and domestic manufacturing, signaling a major expansion of its US operations.

White House suppo

See Full Page